Pharmacotherapeutic management of pulmonary arterial hypertension
JR Anderson, JJ Nawarskas - Cardiology in review, 2010 - journals.lww.com
Pulmonary arterial hypertension (PAH) is a disabling chronic disorder of the pulmonary
vasculature, which is characterized by increased pulmonary artery pressure as a result of …
vasculature, which is characterized by increased pulmonary artery pressure as a result of …
Pharmacotherapeutic Management of Pulmonary Arterial Hypertension
JR Anderson, JJ Nawarskas - Cardiology in Review, 2010 - journals.lww.com
Pulmonary arterial hypertension (PAH) is a disabling chronic disorder of the pulmonary
vasculature, which is characterized by increased pulmonary artery pressure as a result of …
vasculature, which is characterized by increased pulmonary artery pressure as a result of …
Pharmacotherapeutic management of pulmonary arterial hypertension.
JR Anderson, JJ Nawarskas - Cardiology in Review, 2010 - europepmc.org
Pulmonary arterial hypertension (PAH) is a disabling chronic disorder of the pulmonary
vasculature, which is characterized by increased pulmonary artery pressure as a result of …
vasculature, which is characterized by increased pulmonary artery pressure as a result of …
Pharmacotherapeutic management of pulmonary arterial hypertension
JR Anderson, JJ Nawarskas - Cardiology in review, 2010 - pubmed.ncbi.nlm.nih.gov
Pulmonary arterial hypertension (PAH) is a disabling chronic disorder of the pulmonary
vasculature, which is characterized by increased pulmonary artery pressure as a result of …
vasculature, which is characterized by increased pulmonary artery pressure as a result of …